1Kronish IM, Rieckmann N, Shimbo D, et al. Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome[J]. Am J Cardiol,2010,106 (8): 1090.
2Ridker PM, Danielson E, Fonseca FA, et al. Rosnvastatin to prevent vascular events in men and women with elevated C-reactive protein [ J]. N Engl J Med. 2008,359(21 ) : 2195.
3Seeger FH, Blessing E, Gu L, et al. Fibrinogen induces chemotacic activity in endothelial cells [ J]. Acta physiol scand, 2002, 176, 109 -115.
4Kamath s, Lip gy. fibrinogen : biochemishtry, epidemiology and determinants[ J]. Quarterly J Med ,2003,96: 711 - 729.
5Jagroop IA, Mikhailidis DP. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation [ J ]. Clin Appl Thromb Hemost,2008,14 (3) : 295 - 302.
6Yu Shi, Yihua Wu, Chang Bian, et al. Predictive Value of Plasma Fibfinogen Levels in Patients Admitted for Acute Coronary Syndrome Tex Heart Inst J[ J]. 2010,37 (2) : 178 - 183.
